advertisement

Topcon
ARVO TOP TEN 2001

ARVO TOP-TEN

April 28-May 4, 2001, Fort Lauderdale, FL, USA

cj

Chris Johnson

  • Multifocal visual evoked potential (mVEP) results in glaucoma patients correlating very well with conventional automated perimetry findings. It may indeed be a viable reality as a clinical diagnostic tool (Graham et al. ).

  • New ultrahigh resolution images for optical coherence tomography (OCT) showed differentiation of various layers of the retina (including the nerve fiber layer). This approach appears to have great promise for noninvasively monitoring retinal nerve fiber layer thickness (Drexler et al.)

  • The mini symposium entitled The Structure and Function of Retinal Ganglion Cells in Health and Disease was an excellent collection of papers that included the properties of retinal ganglion cells, glial cells, photoreceptor effects in glaucoma, higher visual centers and their relationship to retinal ganglion cell input, and several related topics.

  • Two other mini symposia provided information showing that there is more processing of visual information in the outer plexiform layer and bipolar cells than was previously believed. These findings have significant implications for the input to retinal ganglion cells.

  • The large number of presentations on Frequency Doubling Technology (FDT) with favorable results showed that it has gained wide acceptance and has value as a clinical diagnostic tool.

  • Individual corneal birefringence measures should improve the diagnostic utility of scanning laser polarimetry by applying a more appropriate corneal compensation factor for individual eyes.

  • New, novel neural network approaches have been applied for distinguishing glaucomatous visual field loss and for determining glaucomatous damage to the optic nerve head, and have yielded performance characteristics (sensitivity, specificity, area under the ROC curve) that are considerably better than previous attempts.

  • Glaucoma patients had an increase in plasma endothelin-1 levels following a cold provocative test, whereas normal controls and subjects with Raynaud's syndrome did not. This suggests that some glaucoma patients may have vascular endothelium dysfunction that leads to exaggerated endothelin-1 release and subsequent reduction in ocular blood flow (Nicolela et al.).

 

pp

Paul Palmberg

  • A third generation optical coherence tomography system has been developed which has a 3-µm resolution, which holds promise as a means of objectively monitoring the nerve fiber layer in glaucoma (Drexler et al.). [See also Nature Medicine 2001;7:502-7, for great pictures.]

  • Using a portion of the Advanced Glaucoma Intervention Study visual field data (7-11-year follow-up), progression was called in 49% by pointwise linear regression analysis, 44% by neural network analysis, 43% by clinical consensus, and only 32% by the AGIS criteria, with the best agreement (kappa 0.59) for clinical assessment and pointwise linear regression (Hoffman et al.).

  • A neutralizing anti-TGFB2 human monoclonal antibody has passed safety testing and has yielded an encouragingly better outcome than placebo (mean IOP 14.5 versus 17.8 mmHg for placebo, p = 0.12; 13% back on medication versus 38%, p = 0.29), though a much larger efficacy trial will be needed (Siriwardena et al.).

  • Cultured human nerve head astrocytes at 60 mmHg, but not at ambient pressure, produced nitric oxide synthase type 2, unless inhibited by SN50, an NF-kB inhibitor (Liu and Neufeld).

  • Measuring and compensating for corneal birefringence anomalies improves the performance of the Nerve Fiber Analyzer (GDX) in discriminating glaucomatous from normal eyes (Greenfield et al.).

  • A device that measures multichannel visual evoked potentials with occipital cross electrodes while stimulating 58 points in the visual field achieved good correlation with Humphrey Visual Field results (Graham et al.).

  • A randomized trial of SKT versus ALT showed equal efficacy at 12 months (-6.39 versus -6.03 mmHg), and a trend towards better results in the subset in whom ALT had been performed previously (Hodge et al.).

  • IOP was measured before, and one month and one year after LASIK by three tonometers and the change in measured IOP (means: -2.3 by Goldmann; -3.4 by Tonopen; -5.1 by non-contact) compared to the change in corneal thickness measured by ultrasound (mean 52 Fm), with the authors concluding that the change in IOP is too poorly correlated with the change in corneal thickness to be useful in estimating the 'true' IOP after LASIK (Shinzato et al.).

  • The authors found that cannabinoid-specific agonists bound to receptors in the cytosol, but not cell membranes, of human ciliary body epithelium and trabecular meshwork cells in culture, and stimulated GTP binding (Stamer et al.).

  • In a randomized trial 52 eyes, each were randomized to deep sclerectomy with and without a collagen implant, and the four-year IOPs favored those with the implant (12.7 versus 14 mmHg), as did the percentage of patients at IOP < 21 mmHg off medication (35% versus 63%) (Shaarawy et al.).

 

rr

Robert Ritch

Special web version!

As always, the New Ideas in Glaucoma session on Tuesday morning served as a platform for a variety of innovative and thought-provoking papers.

  • Investigation of mitochondrial gene mutations in glaucoma
    RM Andrews, PG Griffiths, N Howell, DM Turnbull
    Neuro-ophthalmology, Royal Victoria Infirmary, Newcastle, Tyne and Wear, England, Dept of Radiobiology, Galveston, Texas USA.

    A family history of glaucoma is present in anywhere between about 15% and 50% of patients with the most common glaucomas - POAG, juvenile POAG, pigmentary glaucoma, and exfoliative glaucoma. However, the relative risk of maternal transmission is six to eight times greater than paternal transmission. It is difficult to explain this difference in strict Mendelian terms. Mitochondrial DNA is however maternally inherited, suggesting that mitochondrial gene mutations, which have been described in approximately 100 disorders, including sensorineural hearing loss and Leber's optic atrophy, may be a risk factor in glaucoma. Andrews et al undertook whole mitochondrial genome sequencing in 18 families with evidence of maternally inherited normal-tension glaucoma and 16 control families. Whole genome sequence data was used to classify each mtDNA according to haplogroup. Their results suggested that any haplogroup differences detected arose by chance and that the mode of apparent maternal inheritance remains to be explained. Genomic imprinting and trinucleotide repeates remain to be examined, and there is a need to differentiate between glaucoma and the various disorders and risk factors leading to it.

  • Correction for CPA Improves SLP Discriminating Power
    Greenfield DS, Knighton RW, Feuer W, Schiffman J, Zangwill L, Weinreb RN 
    Bascom Palmer Eye Institute, Univ Miami Sch Med; Glaucoma Center, Univ California at San Diego.

    Scanning laser polarimetry (SLP, GDx) provides highly reproducible, quantitative assessments of the peripapillary retinal nerve fiber layer (RNFL) using a polarized diode laser light source (780 nm). Since the RNFL is not the only ocular birefringent structure, the GDx incorporates an anterior segment compensator device designed to neutralize the polarization effects of the cornea and lens. Both the axis and the amount of birefringence are important. The compensator is limited by the assumption that all patients have a fixed slow axis of birefringence (corneal polarization axis, or CPA) of 15 degrees nasally downward and a fixed magnitude of birefringence of 60 nm. Actually, the normal CPA ranges from 90 degrees downward to 54 degrees upward and the magnitude ranges from 0 to 190 nm. Greenfield et al investigated whether correction for CPA could improve the diagnostic precision of SLP for detection of mild to moderate glaucoma. The authors constructed a non-invasive slit-lamp mounted device incorporating two crossed linear polarizers and an optical retarder in order to measure the slow axis of corneal polarization. One eye of each of 53 normals and 33 glaucoma patients were evaluated. Logistic regression analysis was performed and receiver operator characteristic (ROC) curves calculated for 14 retardation parameters. Correction for CPA significantly improved the discriminating power and area under the ROC curve for 5 of 14 summary retardation parameters (average thickness, ellipse average, inferior average, superior average, andtotal integral). Correction for CPA significantly (p<<0.001) increased the correlation between visual function (as measured by corrected pattern standard deviation) and each of these parameters. The authors concluded that correction for CPA narrows the distribution of normative RNFL data, increases the correlation between structural damage and visual function, and significantly improves the diagnostic precision of SLP. 

  • A new method of multifocal objective VEP perimetry for glaucoma detection. 
    SL Graham, AI Klistorner, I Goldberg, FC Billson
    Sydney University, Sydney, NSW, Australia.

    Patients who enjoy taking visual field tests are few and far between. An accurate objective test would not only make patients happy, but would eliminate ambiguity of interpretation due to fluctuation and error. Graham et al tested the ability of multi-focal pattern visually evoked potential (ObjectiVision System) to detect glaucomatous visual field defects. The testing device provided different random patterns to each of 58 points extending out to 32 degrees nasally. The authors examined 100 patients with high- and normal-tension glaucoma who had reproducible Humphrey visual field defects and glaucomatous disc damage and compared to a data base of 100 normals. The Humphrey field defects were demonstrated by VEP amplitude reductions in 95 of100 glaucomatous eyes. Two more were identified on asymmetry analysis, providing a 97% sensitivity. Asymmetry was very useful early in thedisease looking for signs of damage. A normal visual field was present in the second eye of 37 patients, while in 22 of these, multifocal objective perimetry showed a defect. Of these 22, 19 also had a suspicious disc. The authors concluded that multifocal VEP is capable of detecting change prior to visual field testing, but that limitations in the testing conditions still need to be overcome. 

  • Photodynamic modulation of wound healing in glaucoma filtration surgery
    M Diestelhorst, S Grisanti
    University of Cologne, Germany.

    Complications of filtration surgery performed with 5-fluorouracil and mitomycin-C, particularly late bleb leaks, hypotony, and bleb infection, have prompted numerous investigations into alternative modalities for the modulation of wound healing. Diestelhorst and Grisanti studied the safety and efficacy of photodynamic therapy (PDT) using a carboxy-fluorescein derivative (BCECF-AM), a cell-membrane permeable dye absorbed at the target tissue, to control postoperative fibrosis after glaucoma surgery in an open-label study in eyes with finger counting or worse vision. Prior to trabeculectomy 26 eyes receiveda subconjunctival injection of 80 mg BCECF-AM followed by intraoperative illumination with diffuse blue light (450-490 nm) for 8 minutes. The operation was used first in 10 patients and then extended to 16 more. In both groups, mean preoperative IOP in the mid-30s was reduced to the mid-teens postoperatively. Some eyes scarred and others required medication to achieve IOP less than 21 mmHg. No serious complications were encountered. The authors concluded that a prospective, randomized study is warranted.

  • Vitreous Amino Acid Levels in Patients with Glaucoma Undergoing Vitrectomy
    RA Honkanen
    University of Iowa.

    Evidence for a role of excitatory amino acids in the progression of glaucomatous damage has been a major underpinning of the rationale for the investigation of a potential role of neuroprotective therapy in this disease. Recent events have case question on earlier reports of elevated glutamate levels in the vitreous of patients with glaucoma. Honkanen measured amino acid levels in undiluted vitreous samples of 3 open-angle and 5 chronic angle closure glaucoma patients undergoing vitrectomy. For controls, 17 specimens from eyes of non-diabetic patients without any glaucoma diagnosis were selected. Concentrations of 16 amino acids were analyzed. P-values were adjusted by the number of amino acids using Bonferroni's method; adjusted p-values << 0.05 were considered significant. None of the 16 amino acids including glutamate and glycine were significantly elevated in the vitreous of glaucoma eyes compared to controls. The alanine concentration in glaucoma eyes was higher than that of controls, and approached statistical significance. One hypothesis presented as to why these results might be different from the earlier results of Dreyer et al was that glutamate pyruvate transaminase, which converts glutamate to alanine, might have played a role. 

  • Studies on the role of endothelin-1 related vasospasm in glaucoma
    M.T. Nicolela, Dalhousie
    University, Halifax, Nova Scotia.

    Vasospasm has been associated with glaucoma, although the mechanism and consequences of vasospasm in the development of glaucomatous damage remains unknown. Nicolela investigated the possibility that abnormally high levels of thevasoconstrictor endothelin-1 (ET-1), which is involved in Raynaud's phenomenon, cerebral vasospasm, diabetes, and ischemic heart disease, might be involved in glaucoma. Twenty-five patients with glaucoma, 21 normal controls and 6 nonglaucomatous patients with Raynaud's disease underwent total body surface cooling. Blood was collected before and after the cooling test and plasma ET-1 was determined by immunoassay. Visual fields and retinal blood flow (Heidelberg Retina Flowmetry) were measured before and after cooling. Baseline ET-1 levels were not significantly different between glaucoma and controls. Glaucoma patients, however, had a significant increase in ET-1 after cooling, whereas controls did not. Glaucoma patients also had a significant reduction of retinal blood flow in the temporal region (mean decrease of 5.5%, p=0.05), not observed in normal controls. ET-1 levels in Raynaud's patients also tended to increase. The author hypothesized that vascular endothelial dysfunction might to abnormal release of ET-1 under certain conditions, which could adversely affect ocular blood flow.

  • Interleukin-1 alpha is produced by cultured trabecular meshwork cells after phacoemulsification ultrasound exposure
    N Wang, SK Chintala, MA Page, ME Fini, JS Schuman
    Tufts University School of Medicine, Boston, MA.

    IOP often decreases after phacoemulsification. Wang et al tested the hypothesis that this might be due to induction of stress cytokines such as interleukin-1 alpha (IL-1 alpha). Normal and glaucomatous trabecular meshwork (TM) cells were isolated either from cadaver or trabeculectomy specimens. Confluent cultured TM cells were treated with an ultrasonic IA tip with or without phacoemulsification power for 60 seconds, or left untreated. Cell conditioned medium was collected between 4 and 40 hours following treatment. IL-1 alpha levels were determined using an ELISA KIT. IL-1 alpha was not produced by normal untreated TM cells, but was significantly increased in normal TM cells treated with phaco ultrasound power. Treatment did not disrupt cells. Consistent with earlier findings, glaucomatous TM cells produced IL-1 alpha constitutively and the level did not change significantly with treatment (n=4). These results suggest that normal TM cells synthesize IL-1 alpha in response to the stressful stimulation of phacoemulsification. Since IL-1 alpha may increase outflow facility, it may play a role in the reduction of IOP after phacoemulsification.

 


continue reading

Issue 3-1

Change Issue


advertisement

Oculus